Behcet's Syndrome

被引：0

作者：

Xenitidis, Theodoros ^{[1
]}

Henes, Joerg Christoph ^{[1
]}

机构：

[1] Univ Klinikum Tubingen, Med Univ Klin, Abt & Lehrstuhl 2, Hamatol Onkol Klin Immunol Rheumatol, Tubingen, Germany

来源：

AKTUELLE RHEUMATOLOGIE | 2019年 / 44卷 / 04期

关键词：

Vasculitis; Review; Therapy; Behcet's syndrome; PULMONARY-ARTERY INVOLVEMENT; INTERFERON ALPHA-2A; DOUBLE-BLIND; GASTROINTESTINAL MANIFESTATIONS; CLINICAL-FEATURES; NERVOUS-SYSTEM; DISEASE; COLCHICINE; UVEITIS; PREVALENCE;

D O I：

10.1055/a-0979-4510

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Behcet's syndrome (BS) is classified as a variable vessel vasculitis. The clinical picture is very diverse and usually requires interdisciplinary collaboration. Pathogenetically, BS seems to take a middle position between a polygenic autoinflammatory disease and an autoimmune disease. New EULAR recommendations were issued in 2018. The therapy depends on which organs are most affected. Since 2016, adalimumab has been approved for the treatment of posterior ocular involvement. Infliximab, interferon a2a, interleukin-1 antagonists and apremilast may be alternative therapies.

引用

页码：262 / 275

页数：14

共 50 条

[41] Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide
Gurcan, Mert
Esatoglu, Sinem Nihal
Hamuryudan, Vedat
Saygin, Didem
Ugurlu, Serdal
Seyahi, Emire
Melikoglu, Melike
Fresko, Izzet
Yurdakul, Sebahattin
Yazici, Hasan
Hatemi, Gulen
RHEUMATOLOGY, 2020, 59 (09) : 2264 - 2271
[42] When it looks like Behcet's syndrome but is something else: differential diagnosis of Behcet's syndrome: a two-centre retrospective analysis
Lotscher, Fabian
Kerstens, Floor
Krusche, Martin
Ruffer, Nikolas
Koetter, Ina
Turkstra, Franktien
RHEUMATOLOGY, 2023, 62 (11) : 3654 - 3661
[43] A twin study in Behcet's syndrome
Masatlioglu, S.
Seyahi, E.
Turanli, E. Tahir
Fresko, I.
Gogus, F.
Senates, E.
Savran, F. Oguz
Yazici, H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : S62 - S66
[44] Update on the treatment of Behcet's syndrome
Esatoglu, Sinem Nihal
Hatemi, Gulen
INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (05) : 661 - 675
[45] Current management of Behcet's syndrome
Nowatzky, Johannes
Yazici, Yusuf
DRUG DEVELOPMENT RESEARCH, 2011, 72 (07) : 647 - 656
[46] Depression as a Comorbidity in Behcet's Syndrome
de Oliveira Ribeiro, Natalia P.
de Mello Schier, Alexandre R.
Pessoa, Tamires M.
Pereira, Valeska M.
Machado, Sergio
Arias-Carrion, Oscar
Nardi, Antonio E.
Cardoso, Adriana
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (06) : 1041 - 1048
[47] A Contemporary Review of Behcet’s Syndrome
Jingjing Chen
Xu Yao
Clinical Reviews in Allergy & Immunology, 2021, 61 : 363 - 376
[48] Sexual dysfunction in Behcet's syndrome
Talarico, Rosaria
Elefante, Elena
Parma, Alice
Taponeco, Fabio
Simoncini, Tommaso
Mosca, Marta
RHEUMATOLOGY INTERNATIONAL, 2020, 40 (01) : 9 - 15
[49] Behcet's syndrome and the nervous system
Siva, A
Altintas, A
Saip, S
CURRENT OPINION IN NEUROLOGY, 2004, 17 (03) : 347 - 357
[50] Asymptomatic giant coronary aneurysm in an adolescent with Behcet's syndrome
Kahn, Philip J.
Yazici, Yusuf
Argilla, Michael
Srichai, Monvadi
Levy, Deborah M.
PEDIATRIC RHEUMATOLOGY, 2012, 10

← 1 2 3 4 5 →